Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders.
Zhou L, Zeng Z, Egloff AM, Zhang F, Guo F, Campbell KM, Du P, Fu J, Zolkind P, Ma X, Zhang Z, Zhang Y, Wang X, Gu S, Riley R, Nakahori Y, Keegan J, Haddad R, Schoenfeld JD, Griffith O, Manguso RT, Lederer JA, Liu XS, Uppaluri R.
Zhou L, et al. Among authors: zhang f, zhang z, zhang y.
J Immunother Cancer. 2022 Jan;10(1):e004034. doi: 10.1136/jitc-2021-004034.
J Immunother Cancer. 2022.
PMID: 35058328
Free PMC article.